Biotech is going to the dogs – and big profits await Yahoo Finance
Lescault, 43, who enrolled Moose in a clinical trial of an experimental drug designed to help his immune system fight his cancer, represents the type of pet lover …
Biotech is going to the dogs – and big profits await Yahoo Finance
Lescault, 43, who enrolled Moose in a clinical trial of an experimental drug designed to help his immune system fight his cancer, represents the type of pet lover …